Zavegepant has 3 known drug interactions based on U.S. FDA drug labeling data. 2 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Mao Inhibitors, Strong Or Moderate Cyp3a Inducers, Decongestants. Patients taking Zavegepant should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 3
- Major
- 2
- Moderate
- 1
Major (2)
- Zavegepant + Mao Inhibitors— Concomitant administration may result in significant increase in zavegepant exposure. Avoid concomitant administration.
- Zavegepant + Strong Or Moderate Cyp3a Inducers— Concomitant administration may result in decrease in zavegepant exposure. Avoid concomitant administration.
Moderate (1)
- Zavegepant + Decongestants— Concomitant administration may decrease absorption of zavegepant. If unavoidable, administer at least 1 hour after ZAVZP…